Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peanut allergen-specific T cells are a subset of T lymphocytes that recognize and respond to specific protein components (allergens) found in peanuts. These cells play a central role in the immune response underlying peanut allergy, as well as in the development of tolerance during immunotherapy. Peanut-specific CD4+ T cells are key drivers of allergic reactions to peanuts by orchestrating the immune response and promoting IgE production. The most clinically relevant peanut allergens targeted by these T cells include Ara h 1, Ara h 2, and Ara h 3. Analysis of peanut allergen-specific T cell frequency, phenotype, and function provides insight into disease severity, risk stratification, and monitoring therapeutic interventions. Successful immunotherapy can induce new subsets of allergen-reactive regulatory or anergic CD4+ T cells associated with clinical tolerance.
Modulation of T cell phenotype and function (e.g., Th2 to Treg shift), epitope-specific tolerance induction, reduction of IgE-mediated reactivity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peanut Allergen-Specific T Cell.